Dr. Joanna Rhodes, MD
Claim this profileRutgers Cancer Institute of New Jersey
Area of expertise
Follicular Lymphoma
Joanna Rhodes, MD has run 3 trials for Follicular Lymphoma. Some of their research focus areas include:
Non-Hodgkin's Lymphoma
Joanna Rhodes, MD has run 2 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Rutgers Cancer Institute Of New Jersey
Northwell Health/Center For Advanced Medicine
Clinical Trials Joanna Rhodes, MD is currently running
Rituximab vs Mosunetuzumab
for Follicular Lymphoma
This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. It is not yet known if giving rituximab or mosunetuzumab works better in treating patients with follicular lymphoma with a low tumor burden.
Recruiting
2 awards
Phase 3
13 criteria
Tafasitamab + Rituximab
for Lymphoma
This phase II trial tests how well tafasitamab and rituximab work for front-line treatment of patients with post-transplant lymphoproliferative disorder. Post-transplant lymphoproliferative disorder (PTLD) is the name for types of lymphoma that sometimes develop in people who have had a transplant. It can affect people who are taking medicines to suppress their immune system. Tafasitamab injection is in a class of medications called monoclonal antibodies. It works by helping the body to slow or stop the growth of cancer cells. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Giving the combination of tafasitamab and rituximab may work better in treating patients with post-transplant lymphoproliferative disorder.
Recruiting
1 award
Phase 2
20 criteria
More about Joanna Rhodes, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Joanna Rhodes, MD has experience with
- Rituximab
- Lenalidomide
- Obinutuzumab
- Bendamustine Hydrochloride
- Cyclophosphamide
- Umbralisib
Breakdown of trials Joanna Rhodes, MD has run
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joanna Rhodes, MD specialize in?
Joanna Rhodes, MD focuses on Follicular Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Follicular Lymphoma has involved IGH:BCL2 fusion negative patients, or patients who are STAT6 positive.
Is Joanna Rhodes, MD currently recruiting for clinical trials?
Yes, Joanna Rhodes, MD is currently recruiting for 3 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Joanna Rhodes, MD has studied deeply?
Yes, Joanna Rhodes, MD has studied treatments such as Rituximab, Lenalidomide, Obinutuzumab.
What is the best way to schedule an appointment with Joanna Rhodes, MD?
Apply for one of the trials that Joanna Rhodes, MD is conducting.
What is the office address of Joanna Rhodes, MD?
The office of Joanna Rhodes, MD is located at: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903 United States. This is the address for their practice at the Rutgers Cancer Institute of New Jersey.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.